Johnson & Johnson headquarters
Coronavirus-COVID-19Face Masks/Mask MandatesNews

Johnson & Johnson Pauses Vaccine Trial After Patient Becomes Sick

Johnson & Johnson said on Tuesday it would take a few days at least to hear from a safety monitoring panel about its review of the company’s late-stage COVID-19 vaccine trial after announcing that the large study had been paused due to an unexplained illness in one participant.

The pause comes around a month after AstraZeneca Plc also suspended trials of its experimental coronavirus vaccine – which uses a similar technology – due to a participant falling ill. Read More >

Comments are closed.